Tiotropium: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In pharmacology, '''tiotropium''' is a derivative of the quaternary amine scopolamine and is classified as a parasympatholytic, cholinergic antagonist, and a [[bronchodilat...) |
imported>Robert Badgett No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[pharmacology]], '''tiotropium''' is a derivative of the quaternary amine [[scopolamine]] and is classified as a [[parasympatholytic]], [[cholinergic antagonist]], and a [[bronchodilator agent]].<ref>{{MeSH}}</ref> | In [[pharmacology]], '''tiotropium''' is a derivative of the quaternary amine [[scopolamine]] and is classified as a [[parasympatholytic]], [[cholinergic antagonist]], and a [[bronchodilator agent]].<ref>{{MeSH}}</ref> | ||
==Adverse effects== | |||
A [[meta-analysis]] found "a 52% increased risk of mortality associated with tiotropium mist inhaler in patients with [[chronic obstructive pulmonary disease]].". <ref name="pmid21672999">{{cite journal| author=Singh S, Loke YK, Enright PL, Furberg CD| title=Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. | journal=BMJ | year= 2011 | volume= 342 | issue= | pages= d3215 | pmid=21672999 | doi=10.1136/bmj.d3215 | pmc= | url= }} </ref> | |||
==See also== | ==See also== | ||
Latest revision as of 14:51, 23 June 2011
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
In pharmacology, tiotropium is a derivative of the quaternary amine scopolamine and is classified as a parasympatholytic, cholinergic antagonist, and a bronchodilator agent.[1]
Adverse effects
A meta-analysis found "a 52% increased risk of mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease.". [2]
See also
The most up-to-date information about Tiotropium and other drugs can be found at the following sites.
- Tiotropium - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Tiotropium - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Tiotropium - Detailed information from DrugBank.
References
- ↑ Anonymous (2024), Tiotropium (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Singh S, Loke YK, Enright PL, Furberg CD (2011). "Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.". BMJ 342: d3215. DOI:10.1136/bmj.d3215. PMID 21672999. Research Blogging.